NO914288L - Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling - Google Patents

Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling

Info

Publication number
NO914288L
NO914288L NO91914288A NO914288A NO914288L NO 914288 L NO914288 L NO 914288L NO 91914288 A NO91914288 A NO 91914288A NO 914288 A NO914288 A NO 914288A NO 914288 L NO914288 L NO 914288L
Authority
NO
Norway
Prior art keywords
succarinylmethylarcarboxylates
procedures
preparation
new
Prior art date
Application number
NO91914288A
Other languages
English (en)
Other versions
NO914288D0 (no
NO300373B1 (no
Inventor
Richard Paul Dunlap
Neil Warren Boaz
Albert Joseph Mura
Virendra Kumar
Chakrapani Subramanyam
Ranjit Chimanlal Desai
Dennis John Hlasta
Manohar Tukram Saindane
Malcolm Rice Bell
John Joseph Court
Original Assignee
Sterling Winthrop Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sterling Winthrop Inc filed Critical Sterling Winthrop Inc
Publication of NO914288D0 publication Critical patent/NO914288D0/no
Publication of NO914288L publication Critical patent/NO914288L/no
Priority to NO922976A priority Critical patent/NO301116B1/no
Publication of NO300373B1 publication Critical patent/NO300373B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/02Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings
    • C07D275/03Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D275/00Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings
    • C07D275/04Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D275/06Heterocyclic compounds containing 1,2-thiazole or hydrogenated 1,2-thiazole rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to the ring sulfur atom
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/6536Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and sulfur atoms with or without oxygen atoms, as the only ring hetero atoms
    • C07F9/6539Five-membered rings
    • C07F9/6541Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO914288A 1990-11-01 1991-11-01 Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-sakkarinylmetylarylkarboksylater NO300373B1 (no)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NO922976A NO301116B1 (no) 1990-11-01 1992-07-28 Analogifremgangsmåte for fremstilling av terapeutisk aktive tetrahydro-2-sakkarinylmetylarylkarboksylater

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60806890A 1990-11-01 1990-11-01

Publications (3)

Publication Number Publication Date
NO914288D0 NO914288D0 (no) 1991-11-01
NO914288L true NO914288L (no) 1992-05-04
NO300373B1 NO300373B1 (no) 1997-05-20

Family

ID=24434891

Family Applications (1)

Application Number Title Priority Date Filing Date
NO914288A NO300373B1 (no) 1990-11-01 1991-11-01 Analogifremgangsmåte for fremstilling av nye terapeutisk aktive 2-sakkarinylmetylarylkarboksylater

Country Status (17)

Country Link
EP (1) EP0483928A1 (no)
JP (1) JPH04273866A (no)
KR (1) KR920009807A (no)
AU (1) AU642537B2 (no)
CA (1) CA2054653A1 (no)
FI (1) FI103112B (no)
HU (2) HUT63399A (no)
IE (1) IE913827A1 (no)
IL (1) IL99913A (no)
MX (1) MX9101861A (no)
MY (1) MY131053A (no)
NO (1) NO300373B1 (no)
NZ (1) NZ240444A (no)
PT (1) PT99411B (no)
RU (1) RU2114843C1 (no)
SG (1) SG69977A1 (no)
TW (1) TW221294B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0471756B1 (en) * 1989-05-04 1997-10-29 Sanofi Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof
US5306818A (en) * 1990-11-01 1994-04-26 Sterling Winthrop Inc. Tetrahydro 2-saccharinylmerthyl aryl carboxylates
US5512589A (en) * 1990-11-01 1996-04-30 Sterling Winthrop Inc. 2-saccharinylmethyl aryl carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW282463B (no) * 1991-11-15 1996-08-01 Sterling Winthrop Inc
AU668694B2 (en) * 1991-12-19 1996-05-16 Sanofi-Synthelabo Saccharin derivative proteolytic enzyme inhibitors
US5378720A (en) * 1991-12-19 1995-01-03 Sterling Winthrop Inc. Saccharin derivative proteolytic enzyme inhibitors
US5187173A (en) * 1991-12-27 1993-02-16 Sterling Winthrop Inc. 2-saccharinylmethyl and 4,5,6,7-tetrahydro-2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5296496A (en) * 1991-12-27 1994-03-22 Sterling Winthrop Inc. 2-saccharinylmethyl phosphates, phosphonates and phosphinates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
TW226016B (no) * 1991-12-30 1994-07-01 Sterling Winthrop Inc
AU653279B2 (en) * 1991-12-30 1994-09-22 Sanofi Novel 2-saccharinylmethyl heterocyclic carboxylates useful as proteolytic enzyme inhibitors and compositions and method of use thereof
US5684195A (en) * 1994-07-14 1997-11-04 G. D. Searle & Co. Method of preparing sulfmonamides from sulfones
DE4427996A1 (de) * 1994-08-08 1996-02-15 Basf Ag Verfahren zur Herstellung von Saccharincarbonsäuren und -carbonsäureestern
DE19533643A1 (de) * 1995-09-12 1997-03-13 Nycomed Arzneimittel Gmbh Neue cyclische Derivate von Benzolsulfonamiden
JP6239458B2 (ja) * 2014-07-22 2017-11-29 日本曹達株式会社 2−(ベンジルスルフィニル)−1−シクロアルケン−1−カルボン酸エステルの製造方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4276298A (en) * 1978-03-24 1981-06-30 Merck & Co., Inc. 2-Aryl-1,2-benzisothiazolinone-1,1-dioxides and their use as selective protease inhibitors
DE3617976A1 (de) * 1986-05-28 1988-01-14 Alter Sa 1,4-dihydropyridin, verfahren zu dessen herstellung und dessen verwendung in antithrombotischen medikamenten
EP0471756B1 (en) * 1989-05-04 1997-10-29 Sanofi Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof

Also Published As

Publication number Publication date
PT99411A (pt) 1992-10-30
IE913827A1 (en) 1992-05-22
NZ240444A (en) 1994-06-27
FI915163A (fi) 1992-05-02
EP0483928A1 (en) 1992-05-06
IL99913A0 (en) 1992-08-18
IL99913A (en) 1996-11-14
TW221294B (no) 1994-02-21
AU8608391A (en) 1992-05-07
SG69977A1 (en) 2000-01-25
NO914288D0 (no) 1991-11-01
CA2054653A1 (en) 1992-05-02
KR920009807A (ko) 1992-06-25
AU642537B2 (en) 1993-10-21
JPH04273866A (ja) 1992-09-30
HUT63399A (en) 1993-08-30
NO300373B1 (no) 1997-05-20
MX9101861A (es) 1992-07-08
MY131053A (en) 2007-07-31
PT99411B (pt) 1999-04-30
HU211929A9 (en) 1996-01-29
FI915163A0 (fi) 1991-11-01
HU913430D0 (en) 1992-01-28
FI103112B1 (fi) 1999-04-30
RU2114843C1 (ru) 1998-07-10
FI103112B (fi) 1999-04-30

Similar Documents

Publication Publication Date Title
NO905354D0 (no) Nye glykopolypeptidderivater og fremgangsmaate for deres fremstilling.
NO933690L (no) Nye tiopyranopyrrolderivater og deres fremstilling
DK0384288T3 (da) Piperidinforbindelser og deres fremstilling og anvendelse
NO924650D0 (no) Dialkoksy-pyridinyl-benzimidazolderivater, fremgangsmaate for deres fremstilling og deres farmasoeytiske anvendelse
NO900577D0 (no) Cyklosporinholdige preparater og fremgangsmaate for deres fremstilling.
NO904551D0 (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
NO910003L (no) Vitamin e-derivater og fremgangsmaate for deres fremstilling.
NO893196D0 (no) Hybrid-protein-c-sammensetninger og fremgangsmaater for deres fremstilling.
NO914288D0 (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
NO915105L (no) Organiske kopolymerer, fremgangsmaate for deres fremstilling og anvendelse
NO913579D0 (no) Nye 3-aryl-4(3h)kinazolinoner og fremgangsmaate for deres fremstilling.
NO893886D0 (no) Nye aminokinolinforbindelser og fremgangsmaate for deres fremstilling.
NO903096L (no) Termotrope semialifatiske kopolyesteramider og deres fremstilling.
NO904552D0 (no) Quinolonforbindelser og fremgangsmaate for deres fremstilling.
DK0381135T3 (da) Nye hydroxyperoxider og deres anvendelse
DK393489A (da) Benzodiazepinforbindelser og fremgangsmaade til deres fremstilling
NO911047L (no) Labdaner og fremgangsmaate for deres fremstilling.
NO971424D0 (no) Nye heterocyklisk substituerte imidazolo-kinoksalidoner, deres fremstilling og anvendelse
NO921878D0 (no) Nitrittoksyderte lignosulfonater og fremgangsmaate for deres fremstilling
NO900252D0 (no) Cefasporinderivater og fremgangsmaate for fremstilling derav.
NO922608D0 (no) Nye cefalosporinforbindelser og fremgangsmaater til deres fremstilling
NO902094D0 (no) Nye dianhydridforbindelser og fremgangsmaate for deres fremstilling.
NO922976D0 (no) Nye 2-sakkarinylmetylarylkarboksylater og fremgangsmaater for deres fremstilling
NO894697L (no) Penemderivater og fremgangsmaater for deres fremstilling.
NO893565L (no) Etansulfonamidderivater og fremgangsmaate for deres fremstilling.